Position in ACB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,382
-$29,252 QoQ
Shares Held
22,001
-20.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 149 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Derivatives in ACB
reported options exposure · as of Mar 31, 2020CallValue
$270,984
CallShares
2,492
PutValue
$195,785
PutShares
1,801
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ACB ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,302,737 | $165,474,680 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
324,807 | $54,742,970 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,343,554 | $45,519,608 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
72,010 | $39,017,177 | |
| 5 | VTRS |
Viatris Inc
|
2,437,004 | $38,699,622 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
907,024 | $37,215,193 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
861,006 | $29,851,076 | |
| 8 | ALKS |
Alkermes plc.
|
219,935 | $11,524,592 |
All Filings in ACB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,382 | 22,001 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $90,634 | 27,717 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $142,251 | 33,709 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $103,804 | 17,417 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $26,783 | 6,317 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,610 | 2,417 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $72 | 17 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $99 | 17 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $116,224 | 25,157 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $103,849 | 23,656 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $105,941 | 222,566 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $144,533 | 247,066 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $144,752 | 270,566 | Shares | Sole | 2023-09-20 | |
| 2023-03-31 | $185,795 | 266,566 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $232,134 | 251,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $283,772 | 232,600 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $19,932 | 15,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $229,016 | 57,254 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $617,564 | 681,642 | Shares | Sole | 2020-05-13 | |
| 2020-03-31 | $270,984 | 299,100 | Call | Sole | 2020-05-13 | |
| 2020-03-31 | $195,785 | 216,100 | Put | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||